Funding Opportunity Number: W81XWH-17-PRMRP-CTA
Catalog of Federal Domestic Assistance Number: 12.420 Military Medical Research and Development
Submission and Review Dates and Times
Pre-Application Submission Deadline: 5:00 p.m. Eastern time (ET), July 20, 2017
Invitation to Submit an Application: August 2017
Application Submission Deadline: 11:59 p.m. ET, October 26, 2017
End of Application Verification Period: 5:00 p.m. ET, October 31, 2017
Peer Review: December 2017
Programmatic Review: February 2018
Applications to the Fiscal Year 2017 (FY17) Peer Reviewed Medical Research Program (PRMRP) are being solicited for the Defense Health Agency (DHA) J9, Research and Development Directorate, by the U.S. Army Medical Research Acquisition Activity (USAMRAA) using delegated authority provided by United States Code, Title 10, Section 2358 (10 USC 2358). As directed by the Office of the Assistant Secretary of Defense for Health Affairs (OASD[HA]), the DHA manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The execution management agent for this Program Announcement is the Congressionally Directed Medical Research Programs (CDMRP). The PRMRP was initiated in 1999 to provide support for military health-related research of exceptional scientific merit. Appropriations for the PRMRP from FY99 through FY16 totaled $1.371 billion. The FY17 appropriation is $300 million (M).
The vision of the FY17 PRMRP is to improve the health and well-being of all military Service members, Veterans, and beneficiaries. The PRMRP challenges the scientific and clinical communities to address at least one of the FY17 Topic Areas with original ideas that foster new directions along the entire spectrum of research and clinical care. The program seeks applications in laboratory, clinical, behavioral, epidemiologic, and other areas of research to advance knowledge in disease etiology, improve prevention, detection, diagnosis, treatment, and quality of life for those affected by a relevant disease or condition, and to develop and validate clinical care or public health guidelines.
FY17 PRMRP Topic Areas
All applications for PRMRP funding must specifically address at least one of the Topic Areas as directed by Congress and must be directly relevant to the healthcare needs of military Service members, Veterans, and/or beneficiaries. If the proposed research does not specifically address at least one of the FY17 PRMRP Topic Areas, the Government will administratively withdraw the application. The Government reserves the right to reassign the application’s Topic Area if submitted under an inappropriate Topic Area. The FY17 PRMRP Topic Areas are listed below.
Acute Lung Injury
Burn Pit Exposure
Chronic Migraine and Post-Traumatic Headache
Congenital Heart Disease
Early Trauma Thermal Regulation
Emerging Infectious Diseases
Focal Segmental Glomerulosclerosis
Hepatitis B and C
Immunomonitoring of Intestinal Transplants
Inflammatory Bowel Diseases
Nanomaterials for Bone Regeneration
Non-Opioid Pain Management
Pathogen-Inactivated Dried Cryoprecipitate
Polycystic Kidney Disease
Spinal Muscular Atrophy
Sustained-Release Drug Delivery
Vaccine Development for Infectious Disease
Women’s Heart Disease
Research relevant to one or more FY17 PRMRP Topic Areas may be considered for funding. Applicants should select the FY17 PRMRP Program Announcement most appropriate to the stage of the proposed research. Areas of Encouragement related to the FY17 PRMRP Topic Areas have been identified by the Department of Defense (DoD), the Department of Veterans Affairs (VA), and other relevant stakeholders (Appendix 2). Applicants are urged to read and consider these Areas of Encouragement before preparing their applications. The information provided is not exhaustive, and applicants are not restricted to submitting applications that address an Area of Encouragement in this list.
For complete details about this opportunity, click here.